L'Oreal   Report issue

Contributed to NME For profit Phase 3 Phase 4
Founded: Clichy France (1909)
Status: Acquired by Sanofi-Synthelabo (1999) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
2004
NCT01368224
First Marketed Drug
2006
octocrylene
First NDA Approval
2006
ecamsule (Mexoryl SX)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CeraVe | L'Oreal | Loreal USA | LOREAL USA